Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?

the reduction in plasma ACE2 activity reported in ESRD patients treated by dialysis, particularly in female subjects, could limit Ang II degradation leading to increased levels of this peptide, which could contribute to the high prevalence of hypertension and cardiovascular morbidity that afflicts t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wysocki, Jan, Batlle, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Cutting-Edge Renal Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769982/
https://www.ncbi.nlm.nih.gov/pubmed/23787547
http://dx.doi.org/10.1093/ndt/gft240
_version_ 1782284048194863104
author Wysocki, Jan
Batlle, Daniel
author_facet Wysocki, Jan
Batlle, Daniel
author_sort Wysocki, Jan
collection PubMed
description the reduction in plasma ACE2 activity reported in ESRD patients treated by dialysis, particularly in female subjects, could limit Ang II degradation leading to increased levels of this peptide, which could contribute to the high prevalence of hypertension and cardiovascular morbidity that afflicts the dialysis population
format Online
Article
Text
id pubmed-3769982
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-37699822014-09-01 Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity? Wysocki, Jan Batlle, Daniel Nephrol Dial Transplant Cutting-Edge Renal Science the reduction in plasma ACE2 activity reported in ESRD patients treated by dialysis, particularly in female subjects, could limit Ang II degradation leading to increased levels of this peptide, which could contribute to the high prevalence of hypertension and cardiovascular morbidity that afflicts the dialysis population Oxford University Press 2013-09 2013-06-19 /pmc/articles/PMC3769982/ /pubmed/23787547 http://dx.doi.org/10.1093/ndt/gft240 Text en © The Author 2013. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Cutting-Edge Renal Science
Wysocki, Jan
Batlle, Daniel
Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
title Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
title_full Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
title_fullStr Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
title_full_unstemmed Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
title_short Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
title_sort reduced plasma ace2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
topic Cutting-Edge Renal Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769982/
https://www.ncbi.nlm.nih.gov/pubmed/23787547
http://dx.doi.org/10.1093/ndt/gft240
work_keys_str_mv AT wysockijan reducedplasmaace2activityindialysispatientsanotherpieceintheconundrumoffactorsinvolvedinhypertensionandcardiovascularmorbidity
AT batlledaniel reducedplasmaace2activityindialysispatientsanotherpieceintheconundrumoffactorsinvolvedinhypertensionandcardiovascularmorbidity

Ejemplares similares